HIGHLIGHTS
- who: James Oliver from the University of, UK have published the paper: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment, in the Journal: (JOURNAL)
- what: The aim of this study was to discover and validate biomarkers that are associated with DAS28 response to TNFi by comparing changes in the transcriptome of peripheral blood from RA patients who were good- and non-responders to adalimumab therapy. This is most likely pertinent to B and T_cells, which this study has highlighted as important contributors to the transcriptomic response in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.